NASDAQ •
Healthcare •
Medical Devices •
Quote as of 05/07/2026 14:46
Company Profile
IndustryMedical Devices
SectorHealthcare
ExchangeNASDAQ
Market Capitalization15.62 mln
Float9.02 mln
Earnings Date05/29/2026
Piotroski F-Score
4
/ 9
Borderline
Beneish M-Score
-3.41
Reliable
Relative Strength
7
/ 100
Severely lagging
Debt / Equity
-71.53
Negative equity
ROE
-246
Deeply negative
Dividend Yield
0.00%
No dividend
Business Description
20/20 GeneSystems is a Maryland-based medical testing company that helps detect cancer early through blood tests and provides tools to identify viral infections like COVID-19. Beyond direct testing, it runs a shared laboratory facility where new diagnostic companies can develop and launch their products in the U.S. market. It also works with healthcare providers to deliver its cancer screening technology through a software platform.
